$AFCG

TANNENBAUM LEONARD M purchased $93K of AFCG

TANNENBAUM LEONARD M purchased 26,543 shares of Advanced Flower Capital Inc. (AFCG) at $3.49 across 2 trades over 2026-09-22 to 2026-09-23.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 24, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFCG
Neutral
medium confidence
Mentioned
$AFCG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The disclosed purchase adds to the director's ownership but does not materially change the company's capital structure.

02

Market read

A modest insider buy; limited immediate trading relevance.

03

What to watch

Potential upcoming corporate actions or financing events not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: filed today

Background

Advanced Flower Capital Inc. is a publicly traded cannabis company; insider transactions are regularly monitored by investors.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

Director Leonard Tannenbaum bought 26,543 shares for $92,635, increasing his stake to 6,988,989 shares.

Expected impact

Minimal short-term price movement; may provide slight support if market perceives insider confidence.

Evidence & confidence

Form 4 filing is a primary source; however, the $93K purchase is small for a director, limiting actionable impact.

Market effects

None significant; the company operates in the cannabis sector with limited broader impact.

Minimal, confined to investors tracking insider activity in the sector.

Low

Counterpoint

The purchase could be a routine portfolio adjustment rather than a strong bullish signal.

Key entities

  • Leonard Tannenbaum

    10% owner and director of AFCG who executed the purchase.

  • Advanced Flower Capital Inc.

    Issuer of the shares purchased.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): AFC Announces Financial Results for the Second Quarter 2026

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.